Original
Objetivos y metodología de la fase iii de BIOBADASER
Objectives and methodology of BIOBADASER phase iii
Carlos Sanchez-Piedraa,
, M. Victoria Hernández Miguelb, Javier Maneroc, Rosa Rosellód, Jesús Tomás Sánchez-Costaa, Carlos Rodríguez-Lozanoe, Cristina Camposf, Eduardo Cuendeg, Jesús Carlos Fernández-Lopezh, Sagrario Bustabadi, Raquel Martín Domenechj, Eva Pérez-Pampínk, Javier del Pino-Montesl, Ana Milena Millan-Arciniegasm, Federico Díaz-Gonzáleza, Juan Jesús Gómez-Reinok, en representación del Grupo de trabajo BIOBADASER Fase III ◊
a Unidad de Investigación, Sociedad Española de Reumatología, Madrid, España
b Hospital Clínic de Barcelona, Barcelona, España
c Hospital Universitario Miguel Servet, Zaragoza, España
d Hospital General San Jorge, Huesca, España
e Hospital Universitario Dr. Negrín, Canarias, España
f Hospital General Universitario de Valencia, Valencia, España
g Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, España
h Complexo Hospitalario Universitario A Coruña, A Coruña, España
i Hospital Universitario de Canarias, Canarias, España
j Hospital General Universitario de Elda, Alicante, España
k Hospital Clínico Universitario de Santiago, Santiago, A Coruña, España
l Hospital Universitario de Salamanca, Salamanca, España
m Hospital de la Santa Creu i Sant Pau, Barcelona, España
Ver másLeído
11972
Vecesse ha leído el artículo
3255
Total PDF
8717
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 2 | 14 | 16 |
| 2025 6 | 6 | 24 | 30 |
| 2025 5 | 130 | 54 | 184 |
| 2025 4 | 131 | 43 | 174 |
| 2025 3 | 122 | 31 | 153 |
| 2025 2 | 91 | 36 | 127 |
| 2025 1 | 81 | 42 | 123 |
| 2024 12 | 57 | 33 | 90 |
| 2024 11 | 94 | 58 | 152 |
| 2024 10 | 58 | 43 | 101 |
| 2024 9 | 57 | 62 | 119 |
| 2024 8 | 59 | 68 | 127 |
| 2024 7 | 56 | 44 | 100 |
| 2024 6 | 110 | 48 | 158 |
| 2024 5 | 101 | 30 | 131 |
| 2024 4 | 77 | 39 | 116 |
| 2024 3 | 64 | 55 | 119 |
| 2024 2 | 50 | 28 | 78 |
| 2024 1 | 57 | 33 | 90 |
| 2023 12 | 63 | 29 | 92 |
| 2023 11 | 64 | 46 | 110 |
| 2023 10 | 62 | 33 | 95 |
| 2023 9 | 201 | 40 | 241 |
| 2023 8 | 196 | 12 | 208 |
| 2023 7 | 64 | 30 | 94 |
| 2023 6 | 74 | 36 | 110 |
| 2023 5 | 83 | 24 | 107 |
| 2023 4 | 43 | 22 | 65 |
| 2023 3 | 103 | 40 | 143 |
| 2023 2 | 85 | 34 | 119 |
| 2022 1 | 41 | 44 | 85 |
| 2022 12 | 113 | 49 | 162 |
| 2022 11 | 100 | 22 | 122 |
| 2022 10 | 84 | 49 | 133 |
| 2022 9 | 79 | 73 | 152 |
| 2022 8 | 86 | 46 | 132 |
| 2022 7 | 51 | 38 | 89 |
| 2022 6 | 76 | 38 | 114 |
| 2022 5 | 74 | 40 | 114 |
| 2022 4 | 127 | 56 | 183 |
| 2022 3 | 158 | 65 | 223 |
| 2022 2 | 165 | 45 | 210 |
| 2021 1 | 142 | 64 | 206 |
| 2021 12 | 81 | 39 | 120 |
| 2021 11 | 90 | 48 | 138 |
| 2021 10 | 75 | 59 | 134 |
| 2021 9 | 65 | 57 | 122 |
| 2021 8 | 58 | 58 | 116 |
| 2021 7 | 32 | 45 | 77 |
| 2021 6 | 51 | 57 | 108 |
| 2021 5 | 66 | 66 | 132 |
| 2021 4 | 141 | 137 | 278 |
| 2021 3 | 113 | 51 | 164 |
| 2021 2 | 70 | 35 | 105 |
| 2020 1 | 51 | 36 | 87 |
| 2020 12 | 78 | 28 | 106 |
| 2020 11 | 71 | 24 | 95 |
| 2020 10 | 52 | 19 | 71 |
| 2020 9 | 70 | 26 | 96 |
| 2020 8 | 56 | 30 | 86 |
| 2020 7 | 52 | 18 | 70 |
| 2020 6 | 69 | 12 | 81 |
| 2020 5 | 74 | 29 | 103 |
| 2020 4 | 57 | 15 | 72 |
| 2020 3 | 89 | 43 | 132 |
| 2020 2 | 55 | 41 | 96 |
| 2020 1 | 75 | 33 | 108 |
| 2019 12 | 6 | 3 | 9 |
| 2019 10 | 6 | 8 | 14 |
| 2019 9 | 3 | 0 | 3 |
| 2019 8 | 3 | 0 | 3 |
| 2019 7 | 7 | 6 | 13 |
| 2019 6 | 32 | 9 | 41 |
| 2019 5 | 54 | 33 | 87 |
| 2019 4 | 2920 | 18 | 2938 |
| 2019 3 | 69 | 26 | 95 |
| 2019 2 | 48 | 22 | 70 |
| 2019 1 | 84 | 35 | 119 |
| 2018 12 | 57 | 46 | 103 |
| 2018 11 | 0 | 20 | 20 |
| 2018 10 | 0 | 20 | 20 |
| 2018 9 | 0 | 14 | 14 |
| 2018 8 | 0 | 11 | 11 |
| 2018 7 | 0 | 19 | 19 |
| 2018 6 | 0 | 3 | 3 |
| 2018 5 | 0 | 2 | 2 |
| 2018 4 | 0 | 16 | 16 |
| 2018 3 | 0 | 24 | 24 |
| 2018 2 | 0 | 21 | 21 |
| 2018 1 | 0 | 17 | 17 |
| 2017 12 | 0 | 19 | 19 |
| 2017 11 | 0 | 27 | 27 |
| 2017 10 | 0 | 46 | 46 |
| 2017 9 | 0 | 24 | 24 |
Mostrar todo
